![Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/244642bf-33f8-469a-a9ca-0d7de2d9cdb6/gr1_lrg.gif)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology
![Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/2/e001580/F1.large.jpg)
Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer
![Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies](https://www.mdpi.com/cancers/cancers-14-05473/article_deploy/html/images/cancers-14-05473-g001.png)
Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
![Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice](https://www.mdpi.com/cancers/cancers-13-02189/article_deploy/html/images/cancers-13-02189-g001.png)
Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
![Is immunotherapy in the future of therapeutic management of sarcomas? | Journal of Translational Medicine | Full Text Is immunotherapy in the future of therapeutic management of sarcomas? | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-021-02829-y/MediaObjects/12967_2021_2829_Fig3_HTML.png)